An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Top results in this bookTable of Contents
Fabry Disease: Perspectives from 5 Years of FOS.
Mehta A, Beck M, Sunder-Plassmann G, editors.
Oxford: Oxford PharmaGenesis; 2006.
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Essentials of Glycobiology [Internet]. 4th edition.
Varki A, Cummings RD, Esko JD, et al., editors.
Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022.
Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition.
Siegel GJ, Agranoff BW, Albers RW, et al., editors.
Philadelphia: Lippincott-Raven; 1999.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Rare Diseases and Orphan Products: Accelerating Research and Development.
Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development; Field MJ, Boat TF, editors.
Washington (DC): National Academies Press (US); 2010.
National Institute for Health and Care Excellence: Technology Appraisals [Internet].
London: National Institute for Health and Care Excellence (NICE); 2000-.
Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children [Internet].
Francis DO, Chinnadurai S, Sathe NA, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jan. (Comparative Effectiveness Reviews, No. 183.)
Selumetinib (Koselugo): CADTH Reimbursement Review: Therapeutic area: Neurofibromatosis type 1 [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jul.
Velmanase alfa for treating alpha-mannosidosis.
London: National Institute for Health and Care Excellence (NICE); 2023 Dec 13. (National Institute for Health and Care Excellence: Highly specialised technologies guidance, No. HST29.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on